Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/22869
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStupakova, E. G.-
dc.contributor.authorLazareva, G. A.-
dc.contributor.authorGureev, V. V.-
dc.date.accessioned2018-11-13T07:36:16Z-
dc.date.available2018-11-13T07:36:16Z-
dc.date.issued2018-
dc.identifier.citationStupakova, E.G. Correction of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandil / E.G. Stupakova, G.A. Lazareva, V.V. Gureev // Research result: pharmacology and clinical pharmacology. - 2018. - №4(1).- P. 59-71. - DOI: 10.3897/rrpharmacology. 4.25528.ru
dc.identifier.urihttp://dspace.bsu.edu.ru/handle/123456789/22869-
dc.description.abstractPreeclampsia is one of the most serious diseases of the second half of pregnancy and is surely amongst the top three causes of maternal mortality. Therefore, the creation of new drugs for preventing and correcting preeclampsia is an urgent taskru
dc.language.isoruru
dc.subjectmedicineru
dc.subjectobstetricsru
dc.subjectpathological obstetricsru
dc.subjectpathology of pregnancyru
dc.subjectanimal physiologyru
dc.subjectresveratrolru
dc.subjectnicorandilru
dc.subjectpreeclampsiaru
dc.subjectpharmacological preconditioningru
dc.subjectK+ ATP channelsru
dc.subjectratsru
dc.subjectADMAru
dc.titleCorrection of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandilru
dc.typeArticleru
Appears in Collections:Research Result. Pharmacology and Clinical Pharmacology

Files in This Item:
File Description SizeFormat 
Srupakova_Correction_18.pdf1.28 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.